• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 6-K filed by Immuron Limited

    6/4/25 8:00:08 AM ET
    $IMRN
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $IMRN alert in real time by email
    6-K 1 ea0244656-6k_immuron.htm REPORT OF FOREIGN PRIVATE ISSUER

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

    Form 6-K

     

    REPORT OF FOREIGN PRIVATE ISSUER

    PURSUANT TO RULE 13a-16 OR 15d-16 UNDER

    THE SECURITIES EXCHANGE ACT OF 1934

     

    For the Month of June 2025

     

    Commission File Number: 001-38104

     

    IMMURON LIMITED

    (Name of Registrant)

     

    Level 3, 62 Lygon Street, Carlton South, Victoria, 3053, Australia

    (Address of principal executive office)

     

    Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

     

    Form 20-F ☒       Form 40-F ☐

     

    Indicate by check mark whether by furnishing the information contained in this Form, the registrant is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.

     

    Yes ☐       No ☒

     

    If “Yes” is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): 82-

     

     

     

     

     

     

    IMMURON LIMITED

     

    EXPLANATORY NOTE

     

    Immuron Limited (the “Company”) published two announcements (the “Public Notices”) to the Australian Securities Exchange on June 04, 2025 titled:

     

      -   “Application for quotation of securities - IMC”
         
      - “Notice under section 708A”

     

    A copy of the Public Notice is attached as an exhibit to this report on Form 6-K.

     

    This report on Form 6-K (including the exhibit hereto) shall not be deemed to be “filed” for purposes of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) and shall not be incorporated by reference into any filing under the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such filing.

     

    1

     

     

    EXHIBITS

     

    Exhibit
    Number
      Description
    99.1   Application for quotation of securities – IMC
    99.2   Notice under section 708A

     

    2

     

     

    SIGNATURE

     

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

     

      IMMURON LIMITED
       
    Date: June 04, 2025 By: /s/ Phillip Hains
        Phillip Hains
        Company Secretary

     

     

    3

     

     

     

    Get the next $IMRN alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $IMRN

    DatePrice TargetRatingAnalyst
    More analyst ratings